News Grower

Independent coverage of AI, startups, and technology.

Ars Technica May 29, 2026 at 10:30 Big Tech Rising Hot

These researchers would be in Africa fighting ebola—but Trump cut their funding

US Infectious diseases centers launched during COVID have lost their funding under Trump.

Signal weather

Rising

Momentum is building quickly, so this card is a good early entry point into the topic.

By Emily Mullin Original source
These researchers would be in Africa fighting ebola—but Trump cut their funding

As the world struggles to contain the rapidly growing Ebola outbreak in the Democratic Republic of the Congo’s Ituri Province, a vital network of research centers has been unable to help on the ground. The reason: The Trump administration slashed its funding last year, in part due to conspiracy theories about the origins of COVID-19. Established in 2020 by the National Institutes of Health, the Centers for Research in Emerging Infectious Diseases (CREID) Network was conducting research into viruses that emerge from wildlife and spill over to people, including the family of viruses that Ebola belongs to. The network operated 10 sites around the world where these types of disease outbreaks are likely to occur, including in Central and East Africa. (The network was also researching hantavirus, a disease that saw a recent rare outbreak on a cruise ship.) NIH provided CREID with approximately $82 million in funding over five years, and its funding was up for renewal in 2025. But last June, the centers received a stop-work order stating that their research had been deemed “unsafe for Americans and not a good use of taxpayer funding,” and that the agency’s priorities no longer supported the network. Read full article Comments

Stay on the signal

Follow These researchers would be in Africa fighting ebola—but Trump cut their funding

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

Fresh coverage with immediate momentum.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Africa, Covid, and During Covid, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

May 29, 2026 at 10:30 Ars Technica

These researchers would be in Africa fighting ebola—but Trump cut their funding

US Infectious diseases centers launched during COVID have lost their funding under Trump.

May 21, 2026 at 17:14 Hacker News

Chewing gum restores dad's taste and smell years after Covid

Comments

May 8, 2026 at 20:42 Ars Technica

The unprecedented and deadly cruise ship hantavirus outbreak, explained

"This is not COVID," and other reasons why risk to the public is currently low.

Apr 24, 2026 at 21:11 Ars Technica

Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine

Amid RFK Jr.'s anti-vaccine agenda, Moderna withdrew its FDA application last year.

Apr 15, 2026 at 14:00 TechCrunch

Aloe Blacc’s fame means nothing in biotech (and that’s the point)

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better...

Apr 9, 2026 at 15:26 Ars Technica

CDC study shows COVID shot benefits; Trump official blocks release

Study found shots cut urgent care and hospitalization by about 50% in healthy adults.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

4

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page